Skip to content

Clinical Efficacy of Electroacupuncture on Visual Display Terminal-Related Dry Eye and a Study on Conjunctival Cell Transcriptome

Clinical Efficacy of Electroacupuncture on Visual Display Terminal-Related Dry Eye and a Study on Conjunctival Cell Transcriptome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001255
Enrollment
Unknown
Registered
2026-05-18
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye

Interventions

Electroacupuncture group:Electroacupuncture
Artificial tears group:Artificial tears

Sponsors

Shanghai Research Institute of Acupuncture and Meridian
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: 1.Meet the diagnostic criteria of dry eye; 2.Age 18-30 years old (inclusive), both sexes;4.Daily visual display terminal exposure time =8 hours;3. Understand and agree to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: Presence of other ocular diseases (e.g., blepharospasm, conjunctivochalasis, strabismus, amblyopia, glaucoma, fundus lesions) or eyelid disorders (e.g., ptosis, Parkinson's disease, or other conditions affecting blinking function); Autoimmune diseases or severe systemic diseases (e.g., cardiovascular, cerebrovascular, hepatic, renal, hematological, or psychiatric disorders); Pregnancy or lactation; History of active ocular disease or ophthalmic surgery within the past 3 months; Received electroacupuncture or acupuncture treatment within the past 1 month; Hypersensitivity to artificial tears or metals; Wounds, ulcers, infection, or scarring at the acupuncture points; Administration of antihistamines, antidepressants, anticholinergics, or ß-blockers within the past 1 month.

Design outcomes

Primary

MeasureTime frame
The change from baseline in non-invasive tear break-up time after 4 weeks of treatment;

Secondary

MeasureTime frame
Ocular Surface Disease Index-6;Symptom Assessment iN Dry Eye,SANDE;Daily visual display terminal usage duration;non-invasive tear break-up time;Tear Meniscus Height,TMH;Schirmer I Test,SIT;Corneal Fluorescein Staining,CFS; six-item meibomian gland dysfunction grading scale;blink characteristics;Detection of conjunctival cell transcriptome samples;

Countries

China

Contacts

Public ContactMa Xiaopeng

Shanghai Research Institute of Acupuncture and Meridian

maxiaopeng@shutcm.edu.cn13917140446

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 11, 2026